OraSure Technologies Announces 2014 Annual Meeting Date
BETHLEHEM, Pa., Jan. 28, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.
(Nasdaq:OSUR) today announced that its 2014 Annual Meeting of Stockholders is
scheduled to be held on Thursday, May 22, 2014. Further details regarding the
meeting will be provided at a later date.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and
distribution of oral fluid diagnostic and collection devices and other
technologies designed to detect or diagnose critical medical conditions. Its
innovative products include rapid tests for the detection of antibodies to HIV
and HCV at the point of care and testing solutions for detecting various drugs
of abuse. The Company sells the OraQuick® In-Home HIV Test, the first and only
rapid HIV test approved by the U.S. Food and Drug Administration for sale to
the consumer over-the-counter market in the U.S. In addition, the Company is a
leading provider of oral fluid sample collection, stabilization and
preparation products for molecular diagnostic applications. OraSure's
portfolio of products is sold globally to various clinical laboratories,
hospitals, clinics, community-based organizations and other public health
organizations, research and academic institutions, distributors, government
agencies, physicians' offices, and commercial and industrial entities. The
Company's products enable healthcare providers to deliver critical information
to patients, empowering them to make decisions to improve and protect their
For more information on the Company, please go to www.orasure.com.
CONTACT: Company Contact:
Ronald H. Spair
Chief Financial Officer
Press spacebar to pause and continue. Press esc to stop.